FUNMAN
5年前
Chipping away at another brick in the wall--->>>
Senators’ Defense Bill Amendment Would Legalize Medical Cannabis For Military Veterans
Published 3 days ago on November 5, 2021
By Kyle Jaeger
https://www.marijuanamoment.net/senators-defense-bill-amendment-would-legalize-medical-cannabis-for-military-veterans/
Senators could vote on another marijuana-related amendment to a must-pass defense bill that was filed on Thursday. Again, as was the case with a separate recently introduced research-related proposal, it’s not the cannabis banking legislation that stakeholders have been waiting for—but it would have broad implications for federal policy nonetheless.
The new amendment—filed Sens. Brian Schatz (D-HI), Bernie Sanders (I-VT), Tim Kaine (D-VA), Jeff Merkley (D-OR), Ron Wyden (D-OR), Jacky Rosen (D-NV), Alex Padilla (D-CA) and Gary Peters (D-MI)—would add language to the National Defense Authorization Act (NDAA) to federally legalize medical marijuana for military veterans who comply with a state program where they live.
Physicians with U.S. Department of Veterans Affairs (VA) would also be allowed for the first time to issue such recommendations.
Further, it would require VA to study the therapeutic potential of marijuana for pain and reducing opioid misuse.
Separately on Thursday, the House Veterans’ Affairs Committee approved a bill that would require VA to conduct clinical trials on the medical benefits of cannabis for military veterans with PTSD and chronic pain.
The Senate defense legislation amendment is identical to a standalone bill—the Veterans Medical Marijuana Safe Harbor Act—that Schatz filed in April. That measure currently has eight cosponsors, while a House companion version has 14 cosponsors.
Under current federal policy, VA allows its physicians to talk about cannabis use with veterans, but they’re prohibited from issuing recommendations that would allow their patients to obtain medical marijuana from state-legal markets.
Earlier versions of the standalone legislation were introduced in the last two Congresses but did not advance.
For the fiscal years 2022 and 2023, the amendment would set aside $15 million for VA to carry out the mandated medical cannabis research.
The legalization and physician recommendation provisions of the legislation would expire after five years, unless renewed by Congress.
This is the second cannabis amendment to be filed for NDAA.
Schatz and Sen. Dianne Feinstein (D-CA) are also pushing to attach language to the large-scale legislation that deals with removing barriers to research on marijuana’s effects. It’s intended to streamline the application process for researchers who want to investigate cannabis as well as manufacture the plant to be used in studies.
That amendment is identical to standalone legislation that the senators filed in February, alongside Sen. Chuck Grassley (R-IA). The Senate unanimously approved an earlier version of that bill late last year, but it was not taken up by the House by the end of the session.
The research proposal would also clarify that physicians are allowed to discuss the risks and benefits of marijuana with patients and require the U.S. Department of Health and Human Services (HHS) to submit a report on those potential health benefits, as well one on barriers to cannabis research and how to overcome those obstacles.
Dozens of other amendments have filed for NDAA so far, and industry stakeholders are eager to see if the Senate follows the lead of the House and inserts language meant to protect banks that service state-legal marijuana businesses.
For now, the research and veterans amendments are the only cannabis-related measures that have been submitted, but it’s not yet clear when the overall bill will come to the Senate floor. If no senator files a banking amendment, the issue’s fate will be decided by a bicameral conference committee charged with reconciling the differences between the two chambers’ versions of the bill before sending a final proposal to the president.
Senate leadership has spent a lot of time thinking about marijuana policy priorities this session, with Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) saying repeatedly that they think comprehensive reform should advance before banking.
That said, Schumer did say during a recent podcast interview that he’s open to approving banking as part of the defense legislation if it contains social equity components. Booker, for his part, has been more obstinate, saying he “will lay myself down” to block any other senators who seek to pass marijuana banking legislation ahead of broad, justice-focused legalization.
Meanwhile, Feinstein, Schatz and Grassley separately filed the research amendment as part of a massive infrastructure bill earlier this year, but it was not given consideration on the floor.
House lawmakers, for their part, also passed legislation last year to expand cannabis research, but that bill did not advance in the Senate. The House bill, which would allow scientists to study the marijuana that consumers are actually purchasing at dispensaries, was reintroduced last month.
Congressional legislators are also advancing a separate strategy to open up dispensary cannabis to researchers. Large-scale infrastructure legislation that has passed both chambers in differing forms and which is pending final action, expected as soon as Friday, contains provisions aimed at allowing researchers to study dispensary cannabis instead of having to use only government-grown cannabis.
The Senate research measure filed by Feinstein and Schatz includes no such provision to allow scientists to study dispensary cannabis, however.
DropLine
7年前
You're out of your mind... what a crazy statement...
FACTS... MEDMEN... The highest revenue generating 420 company... Most $ generated per square foot...
Ya... no institutional investors... get your facts straight!...
GILDER GAGNON HOWE & CO LLC 12/31/2018 447,671 17,284 4.02 1,326
OSBORN WILLIAMS & DONOHOE LLC 12/31/2018 40,000 30,000 300 119
INTERCONTINENTAL WEALTH ADVISORS, LLC 12/31/2018 12,990 0 0.00 38
HILTON CAPITAL MANAGEMENT, LLC 12/31/2018 10,000 0 0.00 30
VANTAGE INVESTMENT ADVISORS, LLC 09/30/2018 1,000 500 New 3
Institutional Holdings information for this company is filed by major institutions on form 13-F with the Securities and Exchange Commission.
MrPojax
7年前
Let's take a look at MedMen’s ecommerce / tech partner $AHG Alternate Health.
I figured all of the MMEN shareholders would want to know some more about their tech / ecommerce partner.
Ticker $AHG $AHGIF
- Currently trading at the last PP round it did this month.
- SP is $0 .40
- Current MP 27.02M
- Shares outstanding: 53m
- Recent acquisition of manufacturing, and distribution licenses in Humboldt County, CA
- Stong tech / ecommerce relationship w Liberty Health Sciences, and MedMen
- For full DD on Alternate Health $AHG visit their SH board or join the FB group https://www.facebook.com/groups/AHGInvestorsGroup/
Relationship b/w AHG and MedMen?
News Release:
Alternate Health Signs Agreement with Medmen to Launch Statepass Beta in New York Dispensaries
https://www.prnewswire.com/news-releases/alternate-health-signs-agreement-with-medmen-to-launch-statepass-beta-in-new-york-dispensaries-675529303.html
("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international corporation that provides software solutions for the medical cannabis industry, today announced that the Company has entered into a software-as-a-service agreement with MedMen, one of the largest cannabis companies in the U.S., to provide e-commerce and digital payment services. Alternate Health's StatePass system will begin beta testing with MedMen in their New York dispensaries.
"We are very pleased to be working with MedMen as Alternate Health expands into another key state in the U.S. market," said Dr. Michael Murphy, Chairman and CEO of Alternate Health. "The implementation of CanaPass in Canada as well as beta testing in Florida have seen overwhelmingly positive response from our customers and we look forward to serving the medical cannabis community in New York with our state-of-the-art system."
The StatePass system is a cloud-based software platform that manages the end-to-end transactions involved in providing safe access to medical cannabis to eligible patients. The database is accessible by the patient, certified doctors and licensed dispensaries, linked through a seamless interface, and is used to monitor the individual patient and provide enhanced treatment recommendations, with a focus on improving patient outcomes.
"Alternate Health's agreement with MedMen is perfectly aligned with our goal of bringing best-in-class software solutions to the medical cannabis market," said Jay Briggs, Vice President of Operations of Alternate Health. "This is an exciting opportunity to work side-by-side with another leading company in the cannabis industry and open up new revenue streams in New York's tremendously promising market."
JohnCM
8年前
DTC eligible!!
MedMen’s subordinate voting shares are also eligible to be deposited into the Depository Trust Company (DTC), one of the world’s largest securities depositories and electronic clearing and settlement service provider, for its common shares trading under OTC.
MedMen Subordinate Voting Shares Approved for Inclusion on the OTC and Begin Trading on June 18th Under Ticker Symbol “MMNFF”
https://www.businesswire.com/news/home/20180618005417/en/
LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen“ or the “Company“) (CSE: MMEN) (OTCQB: MMNFF) is pleased to announce today that the OTC Markets Group has approved the listing of the Company’s subordinate voting shares on its OTCQB Venture Market under the ticker symbol “MMNFF”. MedMen’s subordinate voting shares will begin trading on the OTCQB at the opening of the market on Monday, June 18th. The Company’s subordinate voting shares continue to be listed on the Canadian Stock Exchange (CSE) under the ticker symbol "MMEN". MedMen’s subordinate voting shares are also eligible to be deposited into the Depository Trust Company (DTC), one of the world’s largest securities depositories and electronic clearing and settlement service provider, for its common shares trading under OTC.
oatsuzn
8年前
Interstate commerce will be sorted out as a part of federal regulations associated with some degree of federal legality(either medical or recreational). Right now we have no federal legality.
Canada has had federally legal medicinal cannabis for over a decade and has been exporting for years. Australia recently legalized medical cannabis on the federal level and is exporting/importing cannabis.
Companies like Cronos and Canopy take advantage of this to supply globally. When you operate in countries that cannabis is federally legal in some form(like Uruguay, Canada, Germany, Australia, Jamaica, Columbia), you can import/export between them as long as you have the correct licenses. In some cases, cultivating/processing in these countries is much cheaper(Israel) than Canada, America or Europe.
America has a loong way to go. We'll have more states on the ballot this year but far short of full legalization(either medicinal or rec). Until some level of federal legalization, it will be a state by state mico market which isn't really indicative of the global cannabis market's potential.
Your investment strategy is up to you. There's pros/cons either way. I just feel investors in this cannabis space need to be alittle more informed and more "visionary" on the actual market. The cannabis industry needs to be compared to others like alcohol, tobacco and coffee. There are different levels of quality and products and not all cannabis is the same. It's not all about who can grow the most. I feel that's an uninformed metric that finance guys use because they don't know any better. Alcohol companies are never compared against each other by how much rye and barley they grow and neither are coffee companies.
oatsuzn
8年前
You mean I must live in one of the other 42 states that haven't legalized adult rec? lol yeah I do. You guys out west seem to forget that most of the country hasn't legalized yet! lol.
The glut is a state market specific issue. Too many licensed cultivators in a small space(the state). Regulators did this to drive out the illegal market. But currently, since weed grown in WA can ONLY be legally sold in WA - hence your low prices and glut.
Once cannabis is legalized nationwide(in some form, medical or adult rec), then interstate commerce can begin(like alcohol and tobacco) and it will be a different story.
Yes, the argument can be made that fancy stores and fancy packaging aren't needed. I guess tell Apple/Starbucks/any fancy wine distributor that...But that's not even the argument I was debating. ATT_for_life made a comment I commonly read on these boards - that all cannabis products are the same and quality won't matter to the consumer so there will be no differentiation in the market. But quality definitely does matter. Taste, smell, effects, organically grown, method of activation(smokable flower, edibles, concentrates, pills etc) does matter. There's a HUGE difference between the Mexican brick weed the cartels push down the pipeline up to the north east and the CA/OR/WA bud that can be gotten out here. Cannabis users search for and prefer anything grown from the west coast and anyone who can successfully receive bud from there AND can verify it's authenticity can pretty much charge a premium and sell out instantly. The only people who routinely buy "regular" weed(reggies) are newbies, teens or people who just don't have the money. This market will be exactly like alcohol/tobacco/coffee etc.